
News & Events
The latest press releases and publications from Onco3R Therapeutics.
Stay in the loop with our latest company milestones!
Approval of First Clinical Trial Application for Novel SIK inhibitor O3R-5671 in Autoimmune Diseases
Approval First Clinical Trial Application